Psychiatry and Neurology, Neurology · Dunmore, PA
NPI
1023098902
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
121 S Apple St
Dunmore, PA, 18512
Phone (570) 963-8803
Groups this clinician bills Medicare through
Medicare paid, 2024
$466K
9,388 services
Medicare patients, 2024
665
Average age 72
Drug cost, 2024
$2.8M
8,239 prescriptions
Company payments, 2025
$30K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vithalbhai D Dhaduk was code 99214 (office e&m - established), 1,935 times for 597 patients. In total Vithalbhai D Dhaduk billed 9,388 services in 30 codes, and Medicare paid $466K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,935 | 597 | $82.44 | $160K |
| 93923 Duplex Scan - Extremity Arteries | Office | 591 | 294 | $88.81 | $52K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 485 | 118 | $0.10 | $49.01 |
| 95886 Electrical Nerve Conductivity | Office | 348 | 155 | $64.19 | $22K |
| 93040 Electrocardiogram | Office | 296 | 294 | $9.16 | $2,711 |
| 95924 Electrical Nerve Conductivity | Office | 293 | 291 | $106.39 | $31K |
| 95923 Electrical Nerve Conductivity | Office | 293 | 291 | $85.07 | $25K |
| 64493 Nerve Block Injection - Back | Office | 224 | 110 | $152.11 | $34K |
| 64494 Nerve Block Injection - Back | Office | 224 | 110 | $95.91 | $21K |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 212 | 82 | $7.69 | $1,630 |
| 64490 Nerve Block Injection - Back | Office | 123 | 60 | $193.31 | $24K |
| 64491 Nerve Block Injection - Back | Office | 122 | 60 | $100.36 | $12K |
| 95910 Electrical Nerve Conductivity | Office | 91 | 90 | $123.13 | $11K |
| 99205 Office E&M - New | Office | 85 | 85 | $151.75 | $13K |
| 95913 Electrical Nerve Conductivity | Office | 67 | 66 | $197.31 | $13K |
By year: 2022 $405K for 12,058 services; 2023 $548K for 11,176 services; 2024 $466K for 9,388 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vithalbhai D Dhaduk prescribed most often to Medicare patients was Gabapentin, with 766 prescriptions and refills. In total Vithalbhai D Dhaduk wrote 8,239 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 766 | 1,063 | 163 | $11K |
| Donepezil Hcl Generic | 722 | 1,160 | 137 | $8,418 |
| Memantine Hcl Generic | 474 | 639 | 89 | $9,300 |
| Levetiracetam Generic | 418 | 516 | 61 | $7,680 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 402 | 493 | 62 | $11K |
| Topiramate Generic | 383 | 582 | 74 | $4,627 |
| Pregabalin Generic | 269 | 285 | 54 | $5,039 |
| Phenobarbital Generic | 249 | 285 | 21 | $6,881 |
| Duloxetine Hcl Generic | 190 | 330 | 42 | $4,244 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 176 | 240 | 37 | $9,669 |
| Ropinirole Hcl Generic | 175 | 215 | 30 | $2,329 |
| Amitriptyline Hcl Generic | 159 | 276 | 41 | $2,154 |
| Carbamazepine Er Carbamazepine | 157 | 215 | 29 | $19K |
| Clonazepam Generic | 144 | 144 | 22 | $1,114 |
| Primidone Generic | 131 | 164 | 18 | $3,293 |
Brand drugs: 532 claims; generic drugs: 7,458 claims; opioid claims: 183.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vithalbhai D Dhaduk $30K ($30K in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 51 | $14K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 14 | $6,627 |
| Pfizer Inc. PFE | 9 | $5,054 |
| Eisai Inc. 4523.T | 22 | $2,416 |
| UCB, Inc. UCB.BR | 17 | $238 |
| Lilly USA, LLC LLY | 18 | $228 |
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $156 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $150 |
| CSL Behring CSL.AX | 4 | $88.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.